DNA-seq of non-BRCA1/2 breast cancer patients to identify putative founder mutations

·发布 2013年8月8日 ·更新 2014年5月3日

样本数

实验数

相关文献

实验描述

Whole exome sequencing identification of putative founder mutations in non-BRCA1/2 breast cancer patients

参考文献

Whole exome sequencing suggests much of non BRCA1/BRCA2 familial breast cancer is due to moderate and low penetrance susceptibility alleles.

Francisco Javier Gracia-Aznarez, Victoria Fernandez, Guillermo Pita, Paolo Peterlongo, Orlando Dominguez, Miguel de la Hoya, Mercedes Duran, Ana Osorio, Leticia Moreno, Ana Gonzalez-Neira, Juan Manuel Rosa-Rosa, Olga Sinilnikova, Sylvie Mazoyer, John Hopper, Conchi Lazaro, Melissa Southey, Fabrice Odefrey, Siranoush Manoukian, Irene Catucci, Trinidad Caldes, Henry T Lynch, Florentine S.M. Hilbers, Christi J. van Asperen, Hans F.A. Vasen, David Goldgar, Paolo Radice, Peter Devilee, Javier Benitez

样本属性

BioSourceProvider

Coriel Cell Repositories, Patient

CellType

lymphocyte

DiseaseState

breast carcinoma, normal

Organism

Homo sapiens

Sex

female, male

实验信息

登记号

E-MTAB-1172

GEO 编号

ERP001755

实验类型

DNA-seq

物种

Homo sapiens

发布日期

2013年8月8日

更新日期

2014年5月3日

提交者

Javier Gracia

外部链接

ArrayExpress 原始页 NCBI GEO：ERP001755

分析服务

DNA-seq of non-BRCA1/2 breast cancer patients to identify putative founder mutations

联系地址

微信公众号